Department of Pathology Microbiology and Immunology Archive — Page 10 of 31

Two researchers stand smiling in a laboratory, with shelves of bottles, equipment, and a teal container behind them.
May 5, 2022

VUMC team discovers how bacterial pathogen survives without water

Vanderbilt researchers are studying a bacterial pathogen that can survive on hospital surfaces — without water — for months, an ability that has helped it become a leading cause of hospital-acquired infections.

3D rendering of numerous red blood cells floating through a blood vessel.
May 5, 2022

COVID-associated bleeding risk

While case reports have noted acquired hemophilia after COVID-19 infection or vaccination, a new study finds no increased risk.

Eric Skaar, PhD, MPH, Hualiang Pi, PhD, and colleagues are studying a regulatory factor in the bacterium that causes the disease anthrax.
April 7, 2022

Study advances understanding of bacterial bioterrorism agent

Vanderbilt researchers have identified a critical regulatory factor in the bacterium that causes the disease anthrax and has been used as a biological weapon.

A suited man stands smiling in a blue-lit laboratory, with scientific equipment and a computer monitor visible around him.
March 31, 2022

Crowe receives national award for COVID antibody research

Vanderbilt’s James Crowe Jr., MD, and Michel Nussenzweig, MD, PhD, of The Rockefeller University, have been jointly awarded the 2022 Harrington Prize for Innovation in Medicine for “groundbreaking work” that enabled the use of human antibodies to treat COVID-19.

Portrait of an older man wearing glasses and a light-colored collared shirt indoors.
March 29, 2022

VUMC mourns loss of noted scientist, teacher Stratton

Charles Stratton IV, MD, associate professor of Pathology, Microbiology & Immunology and of Medicine at Vanderbilt University Medical Center, died March 21 in Nashville. He was 77.

Head-and-shoulders portrait of a smiling man wearing a purple plaid shirt over a white T-shirt.
March 24, 2022

Grant set to support Georgiev’s research to identify new antibodies

Vanderbilt’s Ivelin Georgiev, PhD, has received a three-year, $750,000 award from The G. Harold and Leila Y. Mathers Foundation of Rye Brook, New York, to support research aimed at rapidly identifying potent, disease-fighting antibodies.